The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in the UK, France, and the Netherlands

被引：0
|
作者：
Feher, Michael
Nikolajsen, Annie
Vega-Hernandez, Gabriela
Boegelund, Mette
Brazier, John E.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1344-P
引用
收藏
页码：A349 / A349
页数：1
相关论文
共 50 条
  • [1] The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in North America
    Boegelund, Mette
    Feher, Michael
    Nikolajsen, Annie
    Vega-hernandez, Gabriela
    Brazier, John E.
    [J]. DIABETES, 2015, 64 : A349 - A349
  • [2] Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes
    Jendle, J.
    Torffvit, O.
    Ridderstrale, M.
    Lammert, M.
    Ericsson, A.
    Bogelund, M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (04) : 917 - 923
  • [3] Willingness to Pay for Improvements in Chronic Long-Acting Insulin Therapy in Individuals With Type 1 or Type 2 Diabetes Mellitus
    Lloyd, Andrew
    Nafees, Beenish
    Barnett, Anthony H.
    Heller, Simon
    Ploug, Uffe J.
    Lammert, Morten
    Bogelund, Mette
    [J]. CLINICAL THERAPEUTICS, 2011, 33 (09) : 1258 - 1267
  • [4] Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes
    Feher, Michael D.
    Brazier, John
    Schaper, Nicolaas
    Vega-Hernandez, Gabriela
    Nikolajsen, Annie
    Bogelund, Mette
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2016, 4 (01)
  • [5] Injectable therapies are acceptable and effective in people with early-onset type 2 diabetes
    Gable, D.
    Wilson, L.
    Misra, S.
    [J]. DIABETIC MEDICINE, 2023, 40
  • [6] Willingness to pay for flexible working conditions of people with type 2 diabetes: discrete choice experiments
    Nexo, M. A.
    Cleal, B.
    Hagelund, Lise
    Willaing, I.
    Olesen, K.
    [J]. BMC PUBLIC HEALTH, 2017, 17
  • [7] Willingness to pay for flexible working conditions of people with type 2 diabetes: discrete choice experiments
    M. A. Nexo
    B. Cleal
    Lise Hagelund
    I. Willaing
    K. Olesen
    [J]. BMC Public Health, 17
  • [8] Prioritising injectable therapies in the management of type 2 diabetes
    Frias, Juan Pablo
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (07): : 505 - 508
  • [9] WILLINGNESS TO PAY FOR IMPROVED CLINICAL OUTCOMES AND REDUCED TREATMENT BURDEN ASSOCIATED WITH INSULIN TREATMENT IN PEOPLE WITH TYPE 2 DIABETES IN SOUTH AMERICA
    Feher, M.
    Nikolajsen, A.
    Vega, G.
    Boegelund, M.
    Brazier, J.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A866 - A866
  • [10] Socioeconomic Differences in Preferences and Willingness-to-Pay for Insulin Delivery Systems in Type 1 and Type 2 Diabetes
    Guimaraes, Camila
    Marra, Carlo A.
    Colley, Lindsey
    Gill, Sabrina
    Simpson, Scot
    Meneilly, Graydon
    Queiroz, Regina H. C.
    Lynd, Larry D.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (09) : 567 - 573
12345